rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Chris H. Takimoto

Director

Company insider

Files Form 4 as: Director, ALX Oncology Holdings; Chief Medical Officer, IGM Biosciences; Chief Medical Officer, Forty Seven.

Every Form 4 they filed

In numbers

Trades disclosed
72
Buys
0
Sells
20
Bought
$0
Sold
$9.2M
Companies
3
Companies where not an officer
1
First trade
4 Jan 2019
Last trade
20 Jan 2026
Last filed
21 Jan 2026

Companies traded

Where they are an officer
IGM BiosciencesOfficer · last 13 Sep 20240 buys · 10 sells
Forty SevenOfficer · last 7 Apr 20200 buys · 10 sells
Everywhere else they filed: board seats, 10% stakes, other companies
ALXO ALX Oncology HoldingsDirector · Biotechnology · last 20 Jan 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
20 Jan 2026filed 21 Jan 2026ALXO ALX Oncology Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—40,400 at $0.00filing
20 Jan 2026filed 21 Jan 2026ALXO ALX Oncology Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—40,400 at $0.00filing
21 Jan 2025filed 23 Jan 2025ALXO ALX Oncology Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—40,400 at $0.00filing
13 Sep 2024filed 17 Sep 2024IGM BiosciencesSEC FORM 4 Sold$17K1,487 at $11.54filing
19 Jul 2024filed 23 Jul 2024IGM Biosciencesoption or derivativeSEC FORM 4 Code D—150,000filing
19 Jul 2024filed 23 Jul 2024IGM BiosciencesSEC FORM 4 Code A—43,750filing
19 Jul 2024filed 23 Jul 2024IGM BiosciencesSEC FORM 4 Code A—16,250filing
14 Jun 2024filed 18 Jun 2024IGM BiosciencesSEC FORM 4 Sold$12K1,570 at $7.58filing
15 May 2024filed 18 Jun 2024IGM BiosciencesSEC FORM 4 Code A$15K3,000 at $5.02filing
14 Mar 2024filed 15 Mar 2024IGM BiosciencesSEC FORM 4 Sold$26K2,535 at $10.17filing
13 Mar 2024filed 15 Mar 2024IGM BiosciencesSEC FORM 4 Sold$29K2,889 at $9.88filing
12 Mar 2024filed 14 Mar 2024IGM Biosciencesoption or derivativeSEC FORM 4 Code A—92,500 at $0.00filing
12 Mar 2024filed 14 Mar 2024IGM BiosciencesSEC FORM 4 Code A—46,250 at $0.00filing
29 Nov 2023filed 1 Dec 2023IGM BiosciencesSEC FORM 4 Sold$7,3281,180 at $6.21filing
23 May 2023filed 25 May 2023IGM BiosciencesSEC FORM 4 Sold$15K1,244 at $12.30filing
23 May 2023filed 25 May 2023IGM BiosciencesSEC FORM 4 Sold$19515 at $13.01filing
15 May 2023filed 25 May 2023IGM BiosciencesSEC FORM 4 Code A$11K962 at $11.71filing
4 Apr 2023filed 6 Apr 2023IGM Biosciencesoption or derivativeSEC FORM 4 Code A—52,500 at $0.00filing
4 Apr 2023filed 6 Apr 2023IGM BiosciencesSEC FORM 4 Code A—26,250 at $0.00filing
14 Mar 2023filed 16 Mar 2023IGM BiosciencesSEC FORM 4 Sold$33K1,768 at $18.73filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed20

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.